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Background/aim: Differentiating intestinal Behçet’s disease (BD) from Crohn’s disease (CD) is highly challenging, as they often mimic
each other in terms of clinical manifestations. Endoscopy is an important modality for distinguishing bowel lesions. The study was
designed to identify clinical manifestations that are easily confused and to evaluate the efficacy of endoscopy for distinguishing intestinal
BD from CD by several overlapping signs.
Materials and methods: The data from 111 patients with intestinal BD and 81 patients with CD were retrospectively analyzed. Logistic
regression was applied to establish a prediction model based on endoscopic findings for the differential diagnosis. The diagnostic efficacy
of endoscopy was verified using the area under the receiver operating characteristic (ROC) curve.
Results: Among intestinal BD patients mucocutaneous lesions were the leading clinical manifestations. Gastrointestinal symptoms
were common in CD but were rare in intestinal BD (P < 0.001). CD patients with moderate-to-severe activity were more common than
intestinal BD patients presenting with equivalent activity (P < 0.05). Independent factors that distinguished intestinal BD from CD
were solitary ulcer in the ileocecal area (P < 0.001), perianal abscess (P = 0.049), single segment (P < 0.001), round intestinal ulcer (P
= 0.013), intestinal obstruction (P = 0.035), and fistula (P < 0.001). The scores ranged from –2 to 3. The area under the ROC curve was
0.874 (95% CI: 0.823–0.926) (P < 0.001). With a score of 1.5 as the diagnostic cutoff value, the sensitivity and specificity were 76.3% and
80.6%, respectively.
Conclusion: Mucosal injuries were rarer in patients with intestinal BD than in those with CD. The differentiation model combining
several endoscopy features appeared to be reliable for distinguishing between intestinal BD and CD.
Key words: Intestinal Behçet’s disease, Crohn’s disease, endoscopy, differential diagnosis

1. Introduction
Behçet’s disease (BD) is a systemic vasculitis that causes
inflammation of all sizes of vessels, with involvement of
several organs. Its typical manifestations include recurrent
oral ulcers combined with genital ulcers and skin lesions,
and it frequently involves various other organs, including
the eyes, central nervous system, and gastrointestinal tract
(1). Intestinal BD is diagnosed when there are documented
ulcerative lesions in the terminal ileum or alimentary tract
and clinical manifestations that meet the diagnostic criteria
for BD (2). The incidence of intestinal BD shows a wide
variation across geographies, with low relative frequency
in Turkey (1% of BD patients), moderate frequency in the
China (17% of BD patients), and high frequency in Japan
(50% of BD patients) (1). The real frequency of intestinal
BD might be higher due to the absence of gastrointestinal
manifestations in considerable numbers of patients (3).

Crohn’s disease (CD) is a chronic relapsing, transmural
inflammatory disorder that most commonly affects the
gastrointestinal tract. CD is usually accompanied by other
extragastrointestinal lesions, such as aphthous ulcers,
uveitis, peripheral arthritis, or perianal abscesses that are
easily confused with intestinal BD (4). Currently, there
are no available diagnostic laboratory tests for either
disease. Therefore, the diagnosis of intestinal BD and its
differential diagnosis from CD is challenging for clinicians
due to their similarities in intestinal and extraintestinal
manifestations and pathological findings, especially for CD
accompanied with BD-like extraintestinal manifestations
(5). Some investigators speculate that the two disorders
exist on a spectrum (6). Nevertheless, CD patients require
corticosteroids or immunosuppressant therapies more
often than intestinal BD patients (7). From the perspective
of precision medicine, it is worthwhile to differentiate the
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two diseases. Precise diagnosis may aid the treatment,
improving prognosis. Endoscopy is the first choice for
clinicians to diagnose intestinal ulcers. Studies have shown
that parameters including round ulcer, focal distribution,
and cobblestone appearance in endoscopy are valuable
for differentiating between intestinal BD and CD. In the
present study, we retrospectively analyzed demographics,
clinical manifestations, laboratory findings, disease activity,
and endoscopic and pathological results. We compared
the endoscopy characteristics of intestinal BD and CD.
We found that intestinal BD and CD have overlapping
manifestations, making it difficult to distinguish one
from the other. The severity of intestinal mucosal injury
in BD is slighter than that of CD. Endoscopy parameters
are valuable for differentiating the two conditions. The
differentiation model combining several endoscopy
features appears to be reliable for distinguishing between
intestinal BD and CD.
2. Materials and methods
2.1. Patients enrolled and exclusion criteria
We enrolled 861 patients with BD and 81 patients with
CD admitted to Huadong Hospital, affiliated to Fudan
University, between December 2012 and December 2017
consecutively. All patients with BD conformed to the
International Study Group criteria for BD published in
1990, of which 111 (111/861, 12.9%) had ulcers objectively
confirmed by endoscopy and met the Korean guidelines for
diagnosing intestinal BD published in 2009 (8). Similarly,
81 patients who met the 2010 World Gastroenterology
Organization Practice Guidelines for the diagnosis and
management of inflammatory bowel disease were included
as the CD group (9). Subjects with suspected appearance
of any other gastrointestinal diseases such as intestinal
tuberculosis, nonspecific colitis, or intestinal cancer
were excluded. Patients who were taking nonsteroidal
antiinflammatory drugs or other enterotoxic medications
were excluded. Patients were also excluded if they had
taken glucocorticoids or immunosuppressive agents
during the previous month. Clinical data were collected
after approval by the Institutional Ethics Committee, and
informed consent was provided by all participants.
2.2. Clinical evaluation and data collected
We reviewed general information, including sex, age,
disease course, and clinical manifestations. Laboratory
investigations included hemoglobin (Hb), C-reactive
protein (CRP), and erythrocyte sedimentation rate
(ESR). Ulcer characteristics on endoscopy included size
(diameter ≥1 cm), shape, distribution, and number, as
well as mucosal findings, pathological manifestations, and
complications. The Simple Endoscopic Score of Crohn’s
Disease (SES-CD) was used to evaluate the severity of
intestinal mucosal injury.

2.3. Statistical analysis
Statistical analysis was performed using SPSS 17.0. The
continuous variables were presented as mean ± standard
deviation (SD). Categorical variables were presented as
proportions. In a univariate analysis, continuous and
categorical variables were analyzed by t‑test and χ2 test,
respectively. All endoscopic predictors with P < 0.05 were
entered into logistic regression for multivariate analysis
to test whether a certain variable was independently
associated. Six endoscopic variables were entered into the
logistic regression model. The regression β coefficients
were divided by the smallest coefficient and then rounded
to the nearest integer to derive a risk score. We then
calculated the risk score of the predictors for each patient.
Finally, the differential diagnostic efficacy of the scoring
system was tested by ROC curve. The significance level
was set at P < 0.05.
3. Results
3.1. Demographic and clinical manifestations of
intestinal BD and CD
We recruited a total of 111 patients with intestinal BD (59
females and 52 males) and 81 with CD (32 females and
49 males) during the study period. There was slightly
earlier onset and longer duration in intestinal BD patients
than CD patients (P = 0.001 and P < 0.001, respectively).
Intestinal BD presented more extraintestinal symptoms
than did CD (P < 0.001). Oral ulcer was the most common
presentation (97.3% [108/111]), followed by genital ulcer
(74.77% [83/111]) and skin lesions (49.55% [55/111]).
These signs were rare in CD patients. By contrast,
gastrointestinal symptoms including abdominal pain,
mucous feces, and hematochezia were seen more often in
CD than in intestinal BD (P < 0.001) (Table 1).
3.2. Laboratory results of patients with intestinal BD and
CD
The differences in laboratory results for Hb (intestinal BD:
120.71 ± 20.61 g/L vs. CD: 119.54 ± 22.76 g/L, P = 0.329),
ESR (intestinal BD: 32.70 ± 29.802 mm/h vs. CD: 36.11 ±
33.08 mm/h, P = 0.0.350), and CRP (intestinal BD: 29.89
± 39.62 mg/L vs. CD: 32.54 ± 47.92 mg/L, P = 0.535) were
not statistically significant.
3.3. Endoscopic characteristics in intestinal BD and CD
3.3.1. Endoscopic severity
Among 111 intestinal BD patients, there were 53 (47.75%)
in remission, 37 (33.33%) with mild disease, 21 (18.92%)
with moderate disease, and 0 (0.00%) with severe disease
based on SES-CD scores. Among 81 CD patients, the
number in remission and mild, moderate, and severe
patients were 16 (19.75%), 27 (33.33%), 31 (38.27%), and
7 (8.64%), respectively. Moderate-to-severe endoscopic
lesions were significantly more frequent in CD patients
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Table 1. Comparison of the demographic and clinical manifestations between intestinal BD and CD.
Intestinal BD
(n = 111)

CD
(n = 81)

P-values

Sex (male:female)

1:1.13

1.53:1

0.061

Age at onset (years, mean ± SD)

33.79 ± 13.99

45.67 ± 17.05

0.001

Course (months, mean ± SD)

85.25 ± 62.19

47.78 ± 21.49

<0.001

Abdominal pain

47 (42.34)

55 (67.90)

<0.001

Diarrhea (>3 times/day)

31 (27.93)

43 (53.09)

<0.001

Mucous feces

9 (8.11)

39 (48.15)

<0.001

Hematochezia

14 (12.61)

33 (40.70)

<0.001

Oral ulcer

108 (97.3)

7 (8.64)

<0.001

Genital ulcer

83 (74.77)

0 (0)

<0.001

Erythema nodule/folliculitis

55 (49.55)

1 (1.2)

<0.001

Arthralgia

6 (17.8)

6 (7.3)

0.571

Ocular

7 (6.31)

0 (0)

0.056

Nervous

2 (1.80)

0 (0)

0.621

Hematological

8 (1.80)

0 (0)

0.036

Heart

1 (0.90)

0 (0)

1.000

Vascular

7 (6.31)

0 (0)

0.056

Characteristics
Demographics

Intestinal manifestations (n, %)

Extraintestinal manifestations (n, %)

BD, Behçet’s disease; CD, Crohn’s disease; SD, standard deviation.

than in intestinal BD patients (P = 0.003 and 0.002,
respectively). By contrast, the incidence of remission was
significantly higher among intestinal BD patients than CD
patients (P < 0.001) (Table 2).
3.3.2. Ulcer distribution and count
Ulcers can occur in the upper and lower digestive tract,
and the incidences of ulceration in the gastroduodenal
area (intestinal BD: 6.31% vs. CD: 22.22%, P = 0.001),
descending colon (intestinal BD: 11.71% vs. CD: 24.69%,
P = 0.019), sigmoid colon (intestinal BD: 9.01% vs. CD:
35.80%, P < 0.001), rectum (intestinal BD: 9.01% vs.
CD: 35.80%, P < 0.001), and perianal area (intestinal
BD: 0.90% vs. CD: 18.52%, P < 0.001) were significantly
different. Perianal lesions were characterized by ulcers in
intestinal BD, with the incidence rate of 2.7%. Perianal
abscesses were characteristic features in CD patients, with
an incidence higher than that of intestinal BD (P < 0.001)
(Table 3). Although the ileocecal area is the most involved
area for ulcers in both diseases (P = 0.410), solitary ulcers
in the ileocecal area were more common in intestinal BD
(P < 0.001). Multiple ulcers (>4 ulcers) often presented in
CD (Table 3; Figure 1). Lesions in intestinal BD patients
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involved a single segment more often than did those in CD
patients (P = 0.002).
3.3.3. Ulcerative shape and mucous hyperplasia
Intestinal BD more often presented round ulcers with
mucosal hyperemia around the lesion (P < 0.001, Table 3;
Figure 2a), whereas longitudinal ulcers and cobblestone
appearance were found more frequently in CD than in
intestinal BD patients (P < 0.001, Figure 2b).
3.3.4. Complications
Both diseases presented complications, including
perforation, intestinal stenosis, and fistulas. Intestinal
stenosis and fistula were more common in CD (P = 0.035
and P < 0.001, respectively). Other parameters, including
diameter of ulcer and microscopic pathology, showed no
differences between the two disorders (Table 3).
3.4. Multivariate analysis to determine the independent
predictors and evaluation of the scoring model
The potential indicators with P < 0.05 were entered into
a binary logistic regression for multivariate analysis.
Solitary ulcer in the ileocecal area, single segment
involvement, and round-shaped ulcer were independent
predictors of intestinal BD (P < 0.001, P < 0.001, and P
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Table 2. Comparison of the endoscopic severity between
intestinal BD and CD.
SES-CD

Intestinal BD n (%) CD n (%)

P-values

Remission (≤3)

53 (47.75)

16 (19.75)

<0.001

Mild (4–10)

37 (33.33)

27 (33.33)

0.563

Moderate (11–19) 21 (18.92)

31 (38.27)

0.003

Severe (≥20)

7 (8.64)

0.002

0 (0)

SES-CD, Simplified Endoscopic Score for Crohn’s Disease.
Table 3. Endoscopy findings in differential diagnosis between intestinal BD and CD.
Endoscopy findings

Intestinal BD n (%) CD n (%)

P-value
Univariate analysis Multivariate analysis

Distribution
Esophageal ulcerations

8 (7.21)

4 (4.94)

0.521

Gastroduodenal ulcerations

7 (6.31)

18 (22.22)

0.001

Ileocecal ulcerations

82 (73.87)

64 (79.01)

0.410

Ascending colon

19 (17.12)

23 (28.40)

0.062

Transverse colon

17 (15.32)

21 (25.93)

0.068

NS

Descending colon

13 (11.71)

20 (24.69)

0.019

NS

Sigmoid colon

16 (14.41)

33 (40.74)

<0.001

NS

Rectum

8 (9.01)

29 (35.80)

<0.001

NS

Perianal abscess

1 (0.90)

15 (18.52)

<0.001

0.049

Single segment involved

82 (73.87)

29 (35.80)

0.002

<0.001

Solitary ulcer in ileocecal area

52 (46.85)

16 (19.75)

<0.001

<0.001

Diameter ≥1 cm

18 (16.22)

10 (12.35)

0.453

22 (19.82)

28 (34.57)

0.021

Ulcerative shape
Irregular shape

NS

Round/oval shape

62 (55.86)

20 (24.69)

<0.001

0.013

Stripe ulcer

3 (2.70)

20 (24.69)

<0.001

NS

Annular ulcers

2 (1.80)

1 (1.23)

1.000

Mucous hyperplasia
Polyps

13 (11.7)

18 (22.22)

0.047

NS

Cobblestone sign

2 (1.80)

18 (22.22)

<0.001

NS

Ileocecal valve malformation

31 (27.93)

19 (23.46)

0.486

Perforation

9 (8.11)

5 (6.17)

0.870

Intestinal obstruction

4 (3.60)

29 (35.80)

0.001

0.035

Intestinal fistula

3 (1.80)

14 (17.28)

<0.001

<0.001

Mucous inflammation

78 (70.2)

64 (79.0)

0.864

Granulation tissue

24 (41.6)

30 (52.4)

0.143

Vasculitis

1 (0.9)

1 (1.2)

0.059

Complications

Pathology

Ileocecal region represents terminal ileum and/or cecum.
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Figure 1. Distribution pattern and number of ulcers in intestinal BD and CD. Single ulcer: 1; oligo ulcers: 2–3; multiple ulcers: ≥4.

Figure 2. a) An isolated ulcer in the ileocecal region with mucosal hyperemia around the ulcer in a patient with intestinal BD. b) A
longitudinal ulcer with ileocecal stenosis in a patient with CD. c) Diffuse longitudinal ulcer with cobblestone appearance in a patient
with CD.

= 0.013, respectively), whereas perianal abscess, intestinal
obstruction, and fistula were independent predictors of
CD (P = 0.049, P = 0.035, and P < 0.001, respectively).
The β-coefficient of round-shaped ulcers was the smallest.
The β-coefficients for the other variables were divided
by the minimum regression coefficient, then rounded
to the nearest integer as the scores of each variable. The
scores ranged from –2 to 3 (Table 4). The area under the
ROC curve (95% CI) was 0.874 (0.823–0.926, Figure 3),
which indicating that the scoring system showed good
discrimination.
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4. Discussion
BD was originally reported by Turkish dermatologist
Hulusi Behçet in 1937. It is generally considered to be a
multifactorial disease, characterized by recurrent oral
aphthous ulcers, genital ulcers, and uveitis. Sometimes
BD patients can present with gastrointestinal ulcers at
sites and with clinical manifestations resembling those of
CD. It is easily misdiagnosed because there are no specific
pathological or laboratory markers for the diagnosis of the
entity. Several case reports and clinical studies highlighted
the difficulties in making this distinction (5,10–13). To
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Table 4. Multivariate analysis of endoscopic findings to distinguish intestinal BD from CD
Score

Endoscopy findings

Β-value

P-value

95% CI

YES

NO

Solitary ulcer in ileocecal

–2.322

<0.001

0.032-0.302

2

0

Perianal abscess

2.890

0.049

1.008–321.275

–2

0

Single segment

–1.902

<0.001

0.054–0.415

1

0

Round shape

–1.290

0.013

0.099–0.762

1

0

Intestinal obstruction

1.642

0.035

1.122–23.810

–1

0

Fistula

3.449

<0.001

5.902–167.748

3

0

Ileocecal region represents terminal ileum and/or cecum.

Figure 3. ROC curve of the differentiation model (area under
the ROC curve is 0.874).

date, several discriminating endoscopic findings have been
reported, including round shape, five or fewer lesions, focal
distribution, and absence of aphthous and cobblestone
lesions as features supporting the diagnosis of intestinal
BD (12). Our study confirmed that there were significant
differences to these five predictors. We also found that
intestinal obstruction and fistula were two additional
independent discriminating predictors. In addition to the
differences on endoscopy, Li et al. (11) found that massive
gastrointestinal hemorrhage, fever, and extraintestinal
manifestations were significantly more common in
intestinal BD, while diarrhea, intestinal obstruction, and
perianal abscess were more common in CD. Nevertheless,

clinical manifestations are subjective and easily influenced
by recall bias during a long disease course. Thus, the aim
of this article was to stress the value of endoscopy features
and to establish a differential diagnosis scoring system
with combined multiple signs of endoscopy.
Studies found that over half of intestinal BD patients
were misdiagnosed as having CD at their first visit.
Significant clinical similarities may contribute to the high
rate of misdiagnosis (10). Consistent with past experience,
there are factors leading to misdiagnosis between intestinal
BD and CD. Both diseases have a young age of onset and a
long course. Extraintestinal manifestations can be present
in both diseases, including recurrent oral ulcers, skin
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lesions, and arthritis, as well as gastrointestinal symptoms
such as abdominal pain, diarrhea, mucous feces, and
hematochezia. Furthermore, both diseases are widely
distributed throughout the upper and lower alimentary
tract, and the involvement of the ileum is most common
in both intestinal BD patients (73.87%) and CD patients
(79.01%). However, there are many differences between
intestinal BD and CD on careful analysis.
Research has historically suggested that mucocutaneous
lesions were the most powerful discriminating factors
between the diseases (11). Our study confirmed that
oral ulcers, genital ulcers, mucocutaneous lesions, and
hematological disease were suggestive factors for intestinal
BD on univariate analysis. CD may also be characterized
by oral ulcers, joint pain, and erythematous nodules
(4); however, there are no more than two extraintestinal
symptoms in one CD case. Digestive symptoms of
intestinal BD are similar to those of CD. These include
abdominal pain, diarrhea, and mucosanguineous feces;
however, the incidence was significantly lower than that of
CD. This suggests that mucosal inflammation in patients
with intestinal BD was milder than that of CD. Intestinal
symptoms usually occur on average 4.5–6 years after the
onset of oral ulcers (14). Our statistical result was 85.25
± 62.19 months, significantly longer than the course in
CD patients, possibly associated with a low incidence
of intestinal symptoms in the early diagnosis of BD.
By routine endoscopy we found that the incidence of
asymptomatic patients in intestinal BD was 62.86% (3).
Therefore, clinicians often ignore the presence of ulcerative
lesions when BD patients present to a physician (15).
Enteric ulcers in both disorders can occur in any part
of the alimentary tract, with the ileocecal region being
predominantly affected (11). The mucosal damage in
patients with intestinal BD is lighter than in those with
CD, possibly explaining why digestive symptoms are rare
in patients with intestinal BD. These lesions are primarily
characterized by the following aspects: first, consistent
with the results of another study (16), lesions in intestinal
BD patients tended to be solitary ulcers, especially in the
ileocecal segment; second, single segment involvement
was more common in intestinal BD patients than in CD
patients (73.87% vs. 35.80%, P < 0.001). By contrast,
ulcers in CD were usually widespread, but not confined
to the ileocecal region. Gastroduodenal, descending
colon, sigmoid colon, and rectum involvement were
more frequently present in CD patients than in intestinal
BD patients (P = 0.001, P = 0.019, P < 0.001, and P <
0.001, respectively); third, mucosal hyperplasia including
pseudopolyps and cobblestone appearance, resulting
from repeated inflammation and ulceration associated
with excessive healing processes, were often absent in
intestinal BD (17); fourth, the incidence of complications
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including intestinal obstruction and fistula in patients
with intestinal BD was lower than that of CD. In addition,
there were differences between the two disorders in terms
of ulcer shape and perianal lesions. Round or oval shape,
longitudinal ulcers, and perianal fistulas or abscesses
were also discriminating predictors. These findings were
consistent with those of Li et al. (11) and Zhang et al. (17).
Because the incidence of each index in a disease is very
low, differentiating between these two conditions with a
single parameter is difficult. Therefore, the establishment
of algorithms, comprehensive analyses of endoscopic
results, and combination with clinical history is helpful
for diagnosis. In 2009, Lee et al. generated algorithms
based on colonoscopy and found that more than 90% of
cases could be diagnosed by the algorithm (12). In the
present study, we found that the distinguishing markers of
intestinal BD were solitary ulcer in the ileocecal area, single
segment involvement, and round-shaped ulcer, whereas
distinguishing markers of CD were longitudinal ulcers,
intestinal obstruction, and fistulas. Finally, six endoscopic
parameters were entered into a logistic regression model
to establish the scoring model. Verification was performed
within the dataset with ROC curves. The area under the
ROC curve was 0.874 (95% confidence interval: 0.823–
0.926, P < 0.001), suggesting that the scoring system was
highly reliable for differentiating the two diseases and that
it was convenient for use by clinicians. The sensitivity and
specificity were 73.2% and 84.7%, respectively, for a score
greater than 1.5 in the diagnosis of intestinal BD, indicating
that the reliability of the scoring system was acceptable.
This study has some limitations: first, its retrospective
nature and limited number of patients carry the possibility
of selection bias; second, as the number of cases was
small, we verified the scoring model with the original
dataset. We expect further studies with larger samples and
more prospective studies being carried out to verify this
conclusion. Third, this differentiating model could be used
only if other diseases have been excluded, possibly limiting
its application.
In conclusion, intestinal BD and CD have differences
in terms of clinical and endoscopy features. Extraintestinal
manifestations primarily occurred in intestinal BD,
while the symptoms of the intestine were not substantial,
possibly related to the mild injury of the intestinal
mucosa. The model established according to endoscopy
parameters appeared to be reliable for differentiating
between intestinal BD and CD. The scoring model could
be conveniently used by clinicians.
Acknowledgment
This work was supported by the Clinical Science Innovation
Program of Shanghai Shenkang Hospital Development
Center (SHDC12017129).

YE and GUAN / Turk J Med Sci
References
1.

Hatemi I, Hatemi G, Celik AF. Gastrointestinal involvement in
Behçet disease. Rheum Dis Clin North Am 2018; 44: 45-64.

2.

Lee HJ, Cheon JH. Optimal diagnosis and disease activity
monitoring of intestinal Behçet’s disease. Intest Res 2017; 15:
311-317.

3.

Chen Y, Liu WJ, Zou J, Luo D, Cai JF, Guan JL. Intestinal
pathological changes in Behcet’s disease: a clinical retrospective
study. Fudan Univ J Med Sci 2017; 44: 493-497 (in Chinese).

4.

Tan C, Nkh DB, Brand HS. Oral manifestations of Crohn’s
disease. Ned Tijdschr Tandheelkd 2018; 125: 15-20.

5.

Hakim S, Ramireddy S, Amin M, Gebara S, Cappell MS.
Preoperative misdiagnosis of intestinal Behçet’s syndrome as
Crohn’s disease based on superficial colonoscopic biopsies:
case report and systematic review. Dig Dis Sci 2018; 28: 1-7.

6.

Valenti S, Gallizzi R, De Vivo D, Romano C. Intestinal Behçet
and Crohn’s disease: two sides of the same coin. Pediatr
Rheumatol Online J 2017; 15: 33-40.

7.

Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH.
Long-term clinical outcomes of Crohn’s disease and intestinal
Behcet’s disease. Inflamm Bowel Dis 2013; 19: 99-105.

8.

Cheon JH, Kim ES, Shin SJ, Kim TI, Lee KM, Kim SW, Kim JS,
Kim YS, Choi CH, Ye BD et al. Development and validation
of novel diagnostic criteria for intestinal Behçet’s disease in
Korean patients with ileocolonic ulcers. Am J Gastroenterol
2009; 104: 2492-2499.

9.

Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R,
Fedail S, Gearry R, Goh KL, Hamid S, Khan AG et al. World
Gastroenterology Organization Practice Guidelines for the
Diagnosis and Management of IBD in 2010. Inflamm Bowel
Dis 2010; 16: 112-124.

10.

Feng R, Chao K, Chen SL, Sun CH, Qiu Y, Chen BL, Mao R, He
Y, Cao QH, Xue L et al. Heat shock protein family A member
6 combined with clinical characteristics for the differential
diagnosis of intestinal Behçet’s disease. J Dig Dis 2018; 19: 350358.

11.

Li J, Li P, Bai J, Lyu H, Yang H, Shen B, Qian JM. Discriminating
potential of extraintestinal systemic manifestations and
colonoscopic features in Chinese patients with intestinal
Behçet’s disease and Crohn’s disease. Chin Med J (Engl) 2015;
128: 233-238.

12.

Lee SK, Kim BK, Kim TI, Kim WH. Differential diagnosis of
intestinal Behçet’s disease and Crohn’s disease by colonoscopic
findings. Endoscopy 2009; 41: 9-16.

13.

Nordstrom E, Fischer M. The great masquerader: Behcet’s
disease. BMJ Case Rep 2014; 19: bcr2013202919.

14.

Lopalco G, Rigante D, Venerito V, Fabiani C, Franceschini R,
Barone M, Lapadula G, Galeazzi M, Frediani B, Lannone F
et al. Update on the medical management of gastrointestinal
Behçet’s disease. Mediators Inflamm 2017; 42: 1-11.

15.

Lee HJ, Kim YN, Jang HW, Jeon HH, Jung ES, Park SJ, Hong
SP, Kim TI, Kim WH, Nam CM et al. Correlations between
endoscopic and clinical disease activity indices in intestinal
Behcet’s disease. World J Gastroenterol 2012; 18: 5771-5778.

16.

Politis DS, Katsanos KH, Tsianos EV, Christodoulou DK.
Pseudopolyps in inflammatory bowel diseases: Have we
learned enough? World J Gastroenterol (Engl) 2017; 23: 15411551.

17.

Zhang T, Hong L, Wang Z, Fan R, Zhang M, Lin Y, Cheng M,
Zhou X, Sun P, Lin X et al. Comparison between intestinal
Behçet’s disease and Crohn’s disease in characteristics of
symptom, endoscopy, and radiology. Gastroenterol Res Pract
2017; 10: 1155-1162.

49

